報道指中銀香港(02388.HK)接逾5,000宗紓困措施查詢 已批出數百宗
本地傳媒報道,中銀香港(02388.HK)表示接獲超過5,000宗紓困措施查詢,申請亦有逾1,000宗,已成功批核數百宗個案。其中以物業按揭貸款延期還本,及「中小企抗疫專項貸款計劃」的查詢較多,另「支援分期貸款」措施於上星期推出後,亦陸續接到不少查詢及申請。報道並指,匯豐有逾40%的士及公共小巴貸款已申請「還息不還本」安排,另外亦有逾50%客戶表示將利用貿易融資相關紓緩措施。恆生(00011.HK)的按揭貸款「還息不還本」計劃至今已收到近1,000個查詢,東亞(00023.HK)亦收到逾400宗相關查詢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.